Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/082,584external-prioritypatent/US7060988B2/en
Priority claimed from PCT/US2005/009142external-prioritypatent/WO2005092307A2/en
Application filed by Wyeth CorpfiledCriticalWyeth Corp
Publication of NO20064112LpublicationCriticalpatent/NO20064112L/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Foreliggende oppfinnelse angår for eksempel nye formuleringer og metoder for avlevering av 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzodioksin-5yl)-piperazin-1 -yl]propyl}-N-pyridin-2-yl-benzamid, farmasøytisk akseptable salter derav, strukturelt beslektede forbindelser og/eller metabolitter; så vel som anvendelsen av disse formuleringene og metodene for behandling av sykdom.The present invention relates, for example, to novel formulations and methods for delivering 4-cyano-N - {(2R) -2- [4- (2,3-dihydro-benzodioxin-5yl) -piperazin-1-yl] propyl} -N -pyridin-2-yl-benzamide, pharmaceutically acceptable salts thereof, structurally related compounds and / or metabolites; as well as the application of these formulations and methods of treatment of disease.
NO20064112A2004-03-192006-09-13
Pharmaceutical dosage forms and preparations
NO20064112L
(en)